Primary human bronchial epithelial cell (HBEC) cultures are a useful model for studies of lung health and major airway diseases. However, mechanistic studies have been limited by our ability to selectively disrupt specific genes in these cells. Here we optimize methods for gene targeting in HBECs by direct delivery of single guide RNA (sgRNA) and recombinant Cas9 (rCas9) complexes by electroporation, without a requirement for plasmids, viruses, or antibiotic selection. Variations in the method of delivery, sgRNA and rCas9 concentrations, and sgRNA sequences all had effects on targeting efficiency, allowing for predictable control of the extent of gene targeting and for near complete disruption of gene expression. To demonstrate the value of this system, we targeted SPDEF, which encodes a transcription factor previously shown to be essential for the differentiation of MUC5AC-producing goblet cells in mouse models of asthma.
Introduction
The bronchial epithelium is critical for normal lung function, and altered epithelial function is central to the pathogenesis of major airway diseases including asthma, chronic obstructive pulmonary disease, and cystic fibrosis (1, 2) . The mechanisms underlying normal bronchial epithelial cell function and pathophysiological alterations leading to disease have been studied in various model systems. Mouse and other animal model systems have made indispensable contributions to our understanding of airway epithelial cells, but intra-species differences (3) require that we complement these studies with others in human systems. In vivo investigations in humans are important but are largely confined to observational studies until pre-clinical work justifies clinical trials of therapeutic agents. Studies in immortalized cell lines are also valuable, but these systems are quite limited in their ability to model differentiation of ciliated cells, mucusproducing goblet cells, and other specialized airway epithelial subpopulations with critical roles in human health and disease (4) . Primary air-liquid interface (ALI) cultures of human bronchial epithelial cells (HBECs) have proven to be valuable models due to their ability to recapitulate many in vivo aspects of airway epithelial cell differentiation and function of the human airway epithelium (5, 6) . Whereas gene targeting has enabled elegant mechanistic studies in transgenic mice, analyses of the contributions of specific genes in highly differentiated HBEC models have been limited due to challenges in efficiently targeting genes in these cells.
The advent of CRISPR/Cas9 gene editing technology has transformed our ability to investigate gene function in many model systems and has great potential for therapeutic applications.
Measuring targeting efficiency
Genomic DNA was extracted using the Quick-DNA Miniprep Plus Kit (Zymo Research, Irvine, CA) or the RNA/DNA/Protein Purification Plus Kit (Norgen Biotek, Thorold, ON, Canada) according to manufacturers' protocols. ~1 kb regions containing the gRNA target were amplified using appropriate PCR primers (Table E2 ) and Q5 DNA Polymerase (New England Biolabs, Ipswich, MA) and purified using a PCR Purification Kit (Qiagen, Germantown, MD). In cases where one gRNA was used per sample, PCR products were analyzed by Sanger sequencing (MCLAB, South San Francisco, CA; sequencing primers are shown in Table E2 ), and sequencing read files from cells treated with gene targeting gRNAs (experimental) and with nontargeting gRNAs (control) were analyzed using the Inference of CRISPR Edits (ICE) tool (18) to determine targeting efficiency, defined as percentage of insertions or deletions (indels). In experiments involving deletion of a larger genomic DNA region using a pair of sgRNAs, targeting efficiency was measured via 2% agarose gel electrophoresis followed by quantitation of PCR product bands intensities using Fiji (19) . Band intensities were adjusted according to the estimated masses of each PCR product.
Additional information regarding materials and methods can be found in the Online Data Supplement.
Results

Optimizing genome editing in human primary bronchial epithelial cells
Our general approach to gene editing in HBECs via electroporation of gRNA/rCas9 RNP complex is shown in Figure 1A . After 6 d in submerged culture, cells were placed in suspension and electroporated using recombinant Cas9 enzyme (rCas9) complexed with a CRISPR RNA (crRNA) designed to target SPDEF and a trans-activating CRISPR RNA (tracrRNA). Cells were then placed in culture on Transwell inserts. After reaching confluence (day 0), the apical medium was removed, and cells were maintained in ALI culture. Cells were harvested at d 3 and gene editing efficiency was analyzed by ICE-coupled Sanger sequencing (18) . We began by using rCas9, crRNA, and tracrRNA concentrations previously used with primary human T cells (14) . In initial experiments, we used the 4D-Nucleofector system and found similar editing efficiencies (~30%) using each of 18 nucleofection programs ( Figure 1B ). Editing efficiency was similar when cell numbers were doubled (from 75,000 to 150,000 cells per electroporation). We compared the 4D-Nucleofector and Neon nucleofection systems and did not observe consistent differences in efficiency ( Figure 1C ). However, addition of a second round of electroporation, performed 3 d after the first electroporation, substantially increased efficiency. The 4D-Nucleofector system, which allows for up to 96 simultaneous electroporations, was used for subsequent experiments.
In an attempt to improve editing efficiency, we focused on the type and amount of guide RNA.
As an alternative to using the two component crRNA:tracrRNA system, we tested a single guide RNA (sgRNA) approach. Unlike the crRNA:tracrRNA system, which requires hybridization of two smaller RNA molecules that then complex with rCas9, each sgRNA molecule contains both the crRNA sequence and the Cas9-binding sequence. Compared with a crRNA:tracrRNA targeting the same sequence, delivery of sgRNA resulted in a higher editing efficiency (up to 97% with two electroporations, Figure 1D ). When using sgRNA, increasing the amounts of RNA and rCas9 from levels recommended by the manufacturer (6.0 and 0.67 µM, respectively) to the amount used in our standard crRNA:tracrRNA protocol (6.4 and 3.2 µM) appeared to increase editing efficiency. To evaluate this in more detail, we tested a range of concentrations and ratios of sgRNA:rCas9 ( Figure 1E ). For a given concentration of rCas9, editing efficiency reached near maximal levels when sgRNA was present in a 2-fold molar excess. Efficiency increased when the amount of sgRNA was increased while maintaining a 2:1 ratio.
Strand breaks generated by targeting a single DNA sequence generally result in short indels, but for some applications, such as analysis of non-coding regions of the genome, it is useful to delete larger regions. To test whether our approach could be used to delete larger regions, we introduced pairs of sgRNAs targeting regions that were separated by ~600 nt ( Figure 1F ). We found that this approach efficiently introduced large deletions in HBECs.
Predictable control of gene targeting efficiency in HBECs
Editing efficiency also depends on the gRNA sequence. Despite the availability of numerous prediction algorithms, currently available computational tools cannot robustly predict gRNA editing efficiencies (20) . Since the supply of HBECs can be a limiting factor for some experiments, we investigated whether HBEC editing efficiency could be estimated by testing gRNAs in BEAS-2B, an immortalized human airway epithelial cell line. Four different gRNAs targeting the same SPDEF exon were selected using the MIT Guide Design Tool, and all had high specificity scores. We delivered each to BEAS-2B cells (single electroporation) and primary HBE cells (single or double electroporation) ( Figure 2A ). The relative editing efficiency for the four gRNAs was the same in all cases, with gRNA 2 having the lowest efficiency and gRNA 4 the highest. For each sgRNA, editing efficiency in BEAS-2B cells (one electroporation) was similar to editing efficiency found after two electroporations of HBECs.
Although virus-free gene targeting offers many advantages, virus-based methods are also useful for some applications. Direct determination of virus-based gene targeting efficiency in HBECs requires cloning, virus production, and testing in cell culture. To determine whether the efficiency of virus-based targeting in HBECs could be predicted from results with virus-free targeting with RNPs, we produced lentiviruses that drove expression of each of the four SPDEF gRNAs. Lentiviral delivery of each of these four gRNAs followed by antibiotic selection for transduced cells ( Figure 2B ) produced editing efficiencies that were remarkably similar to efficiencies obtained with the same sequences delivered using the virus-free system without antibiotic selection (Figure 2A ). This suggests that sequence-dependent effects on editing efficiency are largely independent of method of delivery, and that the virus-free methods can be useful for rapid screening of gRNA efficiency prior to subsequent experiments using either virusfree or virus-based methods.
In most cases, the goal of gene targeting is to eliminate functional protein production by the targeted gene. We attempted to use commercially available antibodies against SPDEF but were unable to detect this protein in untargeted cells. As an alternative, we measured the effect of SPDEF targeting on SPDEF function. Previous studies in mice demonstrated that Spdef is required for IL-13-induced production of the airway mucin MUC5AC (15) . We used both virusfree and lentiviral-based methods to target SPDEF in HBECs, allowed cells to differentiate at ALI, stimulated cells with IL-13 for 7 d, and then measured MUC5AC-producing cells by flow cytometry. We found excellent correlation between DNA editing efficiency and reduction in MUC5AC-producing cells ( Figure 2C ). This correlation was seen across four distinct gRNA sequences, providing strong evidence that the effect results from elimination of functional SPDEF protein and not from off-target effects. The most efficient gRNA sequence, SPDEF-4, resulted in >90% SPDEF targeting and >95% reduction in MUC5AC-producing cells with both virus-free and lentiviral delivery.
Highly efficient gene targeting dissects the role of SPDEF in IL-13-induced effects on the HBEC transcriptome
Having established the capacity for efficient targeting of SPDEF, we used the HBEC ALI culture system to study downstream effects of sgRNA/rCas9-mediated non-viral deletion of this critical transcription factor. Analyses of effects of SPDEF targeting on mRNA transcripts showed that SPDEF is required for IL-13-induced increases of MUC5AC ( Figure 3A ). SPDEF was also required for IL-13-induced increases in the goblet cell transcription factor FOXA3 mRNA ( Figure   3B ), consistent with prior work indicating that Foxa3 is downstream of Spdef in mouse airway epithelial cells (15) . In addition, SPDEF was required for induction of CLCA1 ( Figure 3C ), which has been shown to trigger a MAPK13-dependent pathway responsible for mucus production (21) . In addition to increases in these goblet cell transcripts, it is known that IL-13 also suppresses expression of the Club cell secretory protein gene, SCGB1A1 (also known as CCSP), indicating that IL-13 causes a shift of secretory cells from a predominantly Club cell phenotype to a predominantly goblet cell phenotype. We found that the IL-13-induced decrease in SCGB1A1, like the IL-13-induced increase in goblet cell genes, was SPDEF-dependent ( Figure 3D ). In mouse airway epithelial cells, IL-13 stimulation increases expression of both major airway mucins, Muc5ac and Muc5b (22) . In humans, however, IL-13 strongly induces MUC5AC but modestly suppresses MUC5B (23) . The availability of a system for efficient targeting in HBECs allowed us to investigate the role of SPDEF in MUC5B regulation in human cells. Although IL-13-stimulated HBECs that were SPDEF-deficient had levels of MUC5AC, FOXA3, CLCA1, and SCGB1A1 that were similar to those found in unstimulated cells, MUC5B expression was not normalized ( Figure 3A -E). Instead, SPDEF targeting led to a further decrease in expression of MUC5B below the level seen with IL-13 treatment alone. This indicates that therapeutic approaches that target SPDEF in asthma are likely to inhibit expression of both MUC5AC and MUC5B.
We also used transcriptional profiling to examine whether SPDEF targeting had effects outside of the secretory cell lineage. SPDEF targeting had no effects on expression of the ciliated cell marker tubulin beta 4B class IVb (TUBB4B) or the basal cell marker keratin 5 (KRT5) ( Figure 3F and G). We also examined expression of periostin (POSTN), which is highly induced by IL-13 and is expressed predominantly in basal cells (24) . Induction of POSTN was unaffected by targeting SPDEF (Figure 3H ), which indicates that the targeting protocol did not have global effects on IL-13 signaling outside of the secretory cell lineage.
Targeting SPDEF prevents IL-13-induced goblet cell metaplasia and mucostasis
We used histologic staining and immunofluorescence to examine effects of RNP-based gene targeting on the epithelium (Figure 4 ). As expected, IL-13 induced a marked change in the appearance of the epithelium, with the appearance of a large number of AB-PAS and MUC5ACstained goblet cells. Electroporation with rCas9 and a non-targeting control sgRNA had no obvious effects on the appearance of either untreated or IL-13-treated cultures. In contrast, use of a SPDEF-targeting sgRNA resulted in dramatic protection from the effects of IL-13 on mucous metaplasia and MUC5AC staining while the population of acetylated alpha-tubulin containing ciliated cells was maintained.
We previously showed that IL-13-induced changes in mucin composition and organization result in epithelial mucus tethering and impaired mucociliary clearance as measured by transport of fluorescent microspheres in HBEC ALI cultures (23) . We investigated whether rCas9 and sgRNA-mediated gene targeting could be used to identify molecular mechanisms required for this critical function of HBECs ( Figure 5 ). IL-13 stimulation of cells treated with rCas9 and a nontargeting control sgRNA led to a marked reduction in microsphere transport speed, as previously reported for untransfected cells (23) . After targeting SPDEF, IL-13-stimulated cultures had transport speeds that were higher than those found in cells electroporated with control sgRNA and treated with IL-13 and were not significantly different from transport speeds found in untreated control cultures. We conclude that IL-13-induced mucostasis is SPDEFdependent, and that RNP-directed gene targeting enables evaluation of the roles of specific genes in HBEC function.
Discussion
We optimized non-plasmid, non-viral direct delivery of RNPs to HBECs and used this approach to show that the goblet cell transcription factor SPDEF is required for IL-13-induced mucostasis.
The methods we developed should be broadly applicable for mechanistic experiments in the widely used HBEC ALI culture system, which has unique strengths for studies of airway epithelial function in human health and in airway diseases. Using these methods, we demonstrated that SPDEF's central role in goblet cell differentiation is conserved between mouse and human and that disruption of SPDEF prevents IL-13-driven changes in secretory cell transcripts. Some effects of IL-13, including its effects on expression of Muc5b/MUC5B are not conserved between mouse and human, and the use of the HBEC gene targeting system allowed us to show that SPDEF disruption does not restore MUC5B expression in IL-13 treated human cells to unstimulated levels. Since the HBEC ALI culture system is well suited for functional studies, we were also able to show that SPDEF is required for IL-13-induced mucostasis, an important contributor to airway obstruction, morbidity, and mortality in asthma.
We identified several factors that affected gene targeting efficiency in HBECs. By varying the amounts of sgRNA and rCas9, the sgRNA sequence, and the number of electroporations, we were able to obtain SPDEF targeting efficiencies that approached 100% without the need for antibiotic selection. For the set of four SPDEF sgRNAs we tested, targeting efficiency in an immortalized cell line (BEAS-2B) was predictive of efficiency in HBECs. Furthermore, targeting efficiency resulting from direct delivery of RNPs by electroporation also predicted efficiency of targeting by lentiviruses expressing the same gRNA sequence. Although these experiments were limited to a small number of gRNAs targeting the same gene, the results suggest that testing gRNA sequences by direct delivery to cell lines provides an efficient path for selecting optimal gRNA sequences for subsequent use.
Compared with lentiviral delivery, direct delivery of RNPs by electroporation offers several advantages. With direct delivery of RNPs, there is no requirement for plasmid construction, virus production, or antibiotic selection of transduced cells, and there are no concerns about potential effects of viral infection or prolonged expression of Cas9 and gRNAs. By varying delivery conditions, we were able to precisely control targeting efficiency to examine the relationship between the expression of the targeted gene (e.g., SPDEF) and the downstream effects of targeting the gene (e.g., SPDEF) and the effects of gene targeting (e.g., reduction in MUC5AC expression). Although the limited duration of exposure to Cas9 and gRNA might be beneficial in reducing off-target effects, we did not directly assess off-target effects in our experiments.
However, the finding that SPDEF targeting efficiency was highly correlated with downstream changes in MUC5AC expression across the set of four sgRNAs provides confidence that these changes did not result from off-target effects.
The direct delivery method also simplifies targeting of multiple sequences in the genome. We showed that targeting of two sites in the same region led to efficient deletion of larger segments of genomic DNA (>0.5 kb). This approach could be useful for analyzing the functions of regulatory regions, where it may be challenging or impossible to disrupt function with short insertions or deletions produced by individual gRNAs. Although not tested in these experiments, we expect that use of multiple sgRNAs targeting different genes in a single electroporation or in sequential electroporations will allow for efficient analysis of epistatic interactions in HBECs.
Despite the advantages of direct delivery of RNPs, lentiviral delivery may be preferred for experiments involving very large numbers of cells, where cost of sgRNA and rCas9 may be an issue, or for testing large libraries of gRNA sequences in pooled screens (25) .
We chose to target SPDEF based on prior work in transgenic mice that demonstrated a critical role of this transcription factor in goblet cell differentiation (15) . In mouse and human systems,
IL-13 produced by type 2 lymphocytes and innate lymphoid cells drives an increase in
Spdef/SPDEF expression and a large change in the secretory cell population, with a decrease in Club cells and an increase in mucus-producing goblet cells (26, 27) . IL-13 increases expression of the major mucin gene Muc5ac/MUC5AC in both mice and humans (22, 28) . In mice, IL-13 also increases expression of the other major airway mucin gene, Muc5b (22) .
However, in experiments with the HBEC human model system, IL-13 tends to decrease MUC5B expression (23) . This is likely relevant to asthma, since individuals with type 2 high asthma have reduced MUC5B expression as well as increased MUC5AC expression (29) . Experiments in human cell lines found a role for SPDEF in regulation of MUC5AC expression (15, 30) , but these systems do not provide effective models for studying important aspects of bronchial epithelial cell differentiation or mucociliary function. Targeting SPDEF in HBECs allowed us to investigate the role of this transcription factor in a differentiated model of the bronchial epithelium.
We found that targeting SPDEF in HBECs led to a proportional reduction in IL-13-induced expression of MUC5AC. Using conditions that led to highly efficient targeting showed that SPDEF was also required for expression of other genes that are characteristic of goblet cells, including FOXA3 and CLCA1, and for reduced expression of the Club cell gene SCGB1A1 (CCSP). Unlike these other changes in secretory cell gene expression, IL-13-induced suppression of MUC5B was not dependent upon SPDEF. In fact, MUC5B levels were significantly lower when IL-13-stimulated cells had been depleted of SPDEF. This indicates that IL-13-stimulated decreases in MUC5B, which are seen in type 2 high asthma but not in mouse models, are mediated in a SPDEF-independent manner.
We found that SPDEF is required for IL-13 induced mucostasis. We previously showed that IL-13-induced changes in mucus production and organization result in tethering of MUC5AC-rich mucus domains to the airway epithelium, which dramatically impairs mucociliary clearance (23) . The ability to efficiently target genes in the HBEC ALI culture system without apparent nonspecific effects on cell differentiation or mucociliary function allowed us to test the requirement for SPDEF in IL-13 induced mucostasis. Our results suggest that SPDEF could be a valuable target for therapies designed to decrease mucus production and improve mucociliary clearance in asthma or other airway diseases. However, given the important role of MUC5B in airway homeostasis and protection from infection (31) , the finding that SPDEF targeting exacerbates rather than reverses IL-13-induced decreases in MUC5B expression suggests a potential limitation of this approach. 
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